Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Gilead Moves Into Kidney Disease Via Goldfinch Collaboration

May 09 2019

• By Joseph Haas and John Davis

DealWatch_1200x675

Related Content

Finance Watch: Biomatics Closes Second VC Fund; SVB Buys Leerink To Expand Life Science Services

Nov 16 2018

Lundbeck Boosts US R&D Capability With $400m Abide Theraputics Bid

May 06 2019

AZ Targets Viral Oncolytics With Transgene Development Deal

May 02 2019

Asia Deal Watch: Takeda Licenses Curadev STING Agonist To Further Its IO Ambitions

May 08 2019

BioNTech Snaps Up Pancreatic Cancer Antibody, US Infrastructure

May 09 2019

Takeda Offloads Xiidra As Expected, For $3.4bn Upfront To Novartis

May 09 2019

Pfizer Grows In Rare Disease With $810m Dwarfism Company Buy

May 09 2019

Novartis Delighted With Xiidra Deal Despite Eye-Watering Price

May 09 2019

Related Companies

Gilead Sciences, Inc.

Goldfinch Bio, Inc.

Spectrum Pharmaceuticals, Inc.

ImmunGene, Inc.

University of California, Los Angeles

Protagonist Therapeutics, Inc.

Johnson & Johnson

Adimab, LLC

Novartis AG

Regeneron Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

MediWound Ltd.

Vericel Corporation

Amgen, Inc.

AMAL Therapeutics SA

Boehringer Ingelheim GmbH

University of Geneva

Pfizer Inc.

TherAchon AG

BioMarin Pharmaceutical Inc.

BioNTech SE

MabVax Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Skyhawk Therapeutics, Inc.

Purdue Pharma L.P.

Eisai Co., Ltd.

H. Lundbeck A/S

Abide Therapeutics Inc.

AstraZeneca PLC

Transgene S.A.

Additional Topics

Deals Business Strategies Commercial M & A BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.